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Abstract 
 
Background: Research examining the association between physical activity (PA) and prostate 
cancer (PCa) has accumulated; however, few studies have examined this association in the 
context of active surveillance. The current study examines this among men initially diagnosed 
with favourable-risk PCa and managed by active surveillance at Sunnybrook Health Sciences 
Centre in Canada and the Royal Marsden Hospital in the United Kingdom. 
Methods: Participants completed a questionnaire on daily participation in non-leisure, 
transport, and recreational PA. A logistic regression was employed using PA as the independent 
variable and whether the patient reclassified to higher-risk PCa while on active surveillance as 
the dependent variable. Demographic and lifestyle covariates were incorporated in the analysis 
to assess potential confounding and effect modification. 
Results: Men from both hospitals presented with similar clinical and demographic 
characteristics. Total PA was inversely associated with odds of reclassification while on active 
surveillance (p-trend = 0.017). A weaker and non-significant inverse association was observed 
with recreational PA (p-trend = 0.30). Men who participated in weekly vigorous PA were less 
likely to reclassify than those who did not (OR [95%CI]: 0.40 [0.19-0.82]), owing to intensity of 
PA rather than duration. 
Conclusions: Total and vigorous PA were inversely associated with odds of reclassification 
among men initially diagnosed with favourable-risk PCa and managed by active surveillance. 
Given the limitations of this study and that it is the first of its kind, more robust prospective 
observational studies involving objective PA measures are warranted to confirm findings.  
Introduction 
 
Prostate cancer (PCa) remains a major healthcare concern in Canada and globally (1). In 
2016, 22,000 Canadian men were diagnosed with the disease, leading to considerable suffering 
and financial drain of healthcare resources (2). About half of these diagnoses were favorable-
risk, which is unique in a sense that radical treatment is not initially required as it is with more 
aggressive phenotypes (3-5). Instead, favorable-risk patients are periodically assessed through 
analysis of serum biomarkers, histological grading and physical examination to classify disease 
risk (3), a management strategy known as active surveillance. During active surveillance, about 
one-third of men reclassify to higher risk disease and require radical treatment, leading to 
substantial disease- and treatment-related morbidity and mortality (3). Research examining 
factors in the progression of PCa during active surveillance will help to identify effective forms 
of tertiary prevention, so is of great value. 
Physical activity (PA) has demonstrated influence in the evolution of PCa with increasing 
levels of participation being associated with reduced rates of PCa risk  (6-8), biochemical 
recurrence  (9), and PCa-specific death  (10,11). However, few studies have examined the 
influence of PA on PCa in the context of active surveillance  (12,13). Such studies also rely on 
surrogate outcomes of questionable validity (i.e. prostate-specific antigen (PSA)) and involve 
multiple lifestyle interventions, making it difficult to discern the main effect of PA alone  
(13,14). In light of this and considering that PCa grows relatively slow compared to other 
cancers (3), further investigation is required to distinguish whether PA significantly influences 
tumor progression among patients initially diagnosed with favourable-risk PCa and managed by 
active surveillance. 
In a previous study, we demonstrated a protective association between healthier 
lifestyle characteristics and PCa progression  (15). Of the six factors used to categorize a healthy 
lifestyle (PA, dietary intake, body mass index (BMI), waist-to-hip circumference ratio (WHR), 
tobacco use and alcohol use) only PA demonstrated consistent differences between favourable-
risk and reclassified groups in both cohorts analyzed. Men who remained favorable-risk 
compared to those who reclassified to higher risk disease while on active surveillance 
demonstrated a 53.6% (p=0.11) and 41% (p=0.061) increase in total PA at Sunnybrook Health 
Sciences Centre in Canada (SHSC) and the Royal Marsden Hospital (RMH) in the United 
Kingdom, respectively (15). The current study re-evaluates this data more appropriately using 
tertiles instead of continuous PA data with a particular focus on PA as it relates to risk of PCa 
progression during active surveillance. 
Methods 
 
Participants 
 This study received ethics approval from The Research Ethics Board of SHSC. 
Participants were approached in clinic during their regular scheduled appointments/visits with 
intent to recruit during the period of each cohort. Informed consent was obtained from all 
patients approached. From 2010 to 2011, 133 men diagnosed with favourable-risk PCa between 
1995 and 2011 and initially managed with active surveillance were recruited from SHSC. Two 
men were excluded from the study, as they opted for active surveillance despite initial 
recommendation for treatment upon diagnosis. The remaining 131 men were categorized into 
two groups: 1) those who were currently undergoing active surveillance (“favourable-risk”) and 
2) those who were initially managed with active surveillance but later reclassified to higher risk 
disease and subsequently underwent radical treatment (“reclassified”). In 2013, 112 men 
diagnosed with favourable-risk PCa between 1999 and 2013 and initially managed with active 
surveillance were recruited from the RMH. One hundred and six men returned the 
questionnaire with sufficient data and were categorized into two groups: 1) those who had low- 
to intermediate-risk disease (“favourable-risk”) and 2) those who initially presented with 
favourable-risk disease but later reclassified to higher risk disease and/or underwent radical 
treatment (“reclassified”). Categorizing men from the RMH cohort differently than those from 
the SHSC cohort was done in response to differences in available data.  
 “Favorable-risk” PCa was followed according to the D’Amico definition (Gleason score ≤ 
6 (3+3), PSA < 10 mg/ml, and clinical stage ≤ T2a) with some exception (i.e. men with Gleason 7 
(4+3), provided they are older than 70 years and only have a small proportion of Gleason 4 
pattern) (16). Reclassification to higher risk disease was triggered by Gleason pattern 4 or 5 on 
repeat biopsy or when extensive increases in Gleason pattern 3 volume were found in patients 
under 55 years (16). Reclassification for men in the RMH cohort was similar; however, the 
occurrence of adverse PSA kinetics (PSA doubling time of >3 years or a PSA velocity of <2.0 per 
year) without a confirmed biopsy upgrade warranted reclassification, as adverse PSA kinetics 
have been shown a significant predictor of disease progression in this cohort (17). 
Assessment of lifestyle characteristics 
A modified version of the WHO STEPwise approach to chronic disease risk factor 
surveillance- Instrument version 3 [11] was used to obtain information on demographics, 
tobacco use, alcohol use, PA, dietary intake, medications and supplements, history of disease, 
and general health. Men were asked to recall information from the time they were on active 
surveillance (i.e. reclassified men reported information from diagnosis to time of 
reclassification while men who remained favourable risk reported information from diagnosis 
to time of questionnaire. The PA section was identical to the Global Physical Activity 
Questionnaire (GPAQ), which has previously demonstrated weak to moderate strength 
correlation between self-report and objective measures (i.e. accelerometer and pedometer) of 
total PA (18). Height, weight, and WHR were also measured. The survey was administered to 
men in the SHSC cohort through personal interviews at the time of consent and to men in the 
RMH cohort as a take home survey (unmodified) right after consent was obtained. 
Data regarding working/non-leisure, transport-related and recreational PA were 
collected. Non-leisure PA referred to PA done as part of paid or unpaid work, household 
maintenance, or study/training. Recreational physical activities included walking, jogging, 
swimming, sports, gym-based activities (e.g. treadmill, weight-lifting, etc.) and referred to 
planned activity for health benefit or enjoyment excluding non-leisure PA. Patients were also 
asked of their perceived intensity (i.e. moderate or vigorous) for each activity. Vigorous-
intensity PA was defined as strenuous PA causing large increases and breathing and heart rate 
whereas moderate-intensity PA was defined as causing small increases in breathing and heart 
rate. Specific metabolic equivalent task (MET) values were assigned to all physical activities, 
according to the Compendium of Physical Activities (19). Values were further adjusted by BMI 
and age at diagnosis according to an equation established by Byrne et al (20), as shown below:  
Adjusted MET value for activity = Standard MET value for activity * ([3.5 ml 
O2/kg·min]/[3.6145 – (0.0367 * BMI) – (0.0038 * age) + (0.1790 * 2)]) 
Indices were developed to assess each patient’s diet as a whole, as well as his fruit and 
vegetable intake. Details regarding this development have been reported previously  (15). 
Briefly, for food groups thought to promote or hinder PCa growth, heavier consumption was 
allotted fewer and greater points, respectively. The overall dietary score was equivalent to the 
sum of points for each food group. The fruits and vegetable score was equal to sum of the 
points accrued for regular consumption of tomato products, cruciferous vegetables, soy 
products, red grapes and/or red wine, and berries. Scores were portioned into tertiles along 
with BMI, and WHR and were included as covariates in the regression model. Tobacco use was 
dichotomized as never and ever smoked, since few reported current tobacco use (n=7). Alcohol 
consumption was categorized as none, light (less than daily), moderate (daily but <3 drinks/day) 
and heavy (>3 drinks/day).  
Statistical Analysis 
 All statistical analyses were performed using SAS 9.4 (SAS Institute, Cary NC). A power 
calculation was performed for the original study (15) and a sample size of 68 individuals per 
group was determined a priori to enable the detection of a moderately sized effect of d = 0.43, 
with a power of 0.8 and one-sided α of 0.05, reflecting differences between the two groups on 
lifestyle factors. A binary logistic regression analysis was performed with PA as the independent 
variable of interest and whether or not patients reclassified during their time on active 
surveillance as the dependent variable. Total and recreational PA were categorized into tertiles 
of MET-hrs/wk by cohort, since method of data collection might have influenced self-report 
values of PA  (15,21). Since a substantial number of participants reported not participating in 
vigorous intensity PA (n = 88), it was dichotomized into any or no weekly participation. The first 
model accounted for age at diagnosis, time on surveillance and recruitment centre. The second 
model further accounted for diet and BMI, and tobacco and alcohol use, and family history of 
PCa. Fruit and vegetable intake score and WHR were excluded after demonstrating notable 
muticollinearity (tolerance statistic <0.4) with dietary score and BMI, respectively. Since the 
latter two demonstrated a stronger association with the outcome and greater influence the 
association of interest, they were retained in the final model. We tested for evidence of a linear 
trend by modeling the median value of each tertile of total and recreational PA as a continuous 
term. We considered potential interactions of PA with age at diagnosis, time on surveillance 
and other lifestyle characteristics. Statistical significance for all analyses was denoted by a p-
value <0.05. 
Results 
 Both cohorts presented with similar clinical and demographic characteristics, as 
reported previously (15). Briefly, 93% of favorable-risk and 83% of reclassified men from the 
SHSC cohort had a Gleason score of 6, while men from RMH presented similarly with 96.1% and 
93.3%, respectively. Seven percent and 13% from the favorabe-risk and reclassified groups 
were diagnosed with Gleason score 7 at SHSC, respectively, while this rate was only 3.9% and 
3.3% at RMH. Patient characteristics by levels of PA are displayed in Table I. Briefly, men who 
completed greater levels of total PA also completed greater amounts of recreational PA and 
were more likely to participate in vigorous intensity PA. They were also, on average, younger at 
diagnosis and reclassification (reclassified only) or last follow-up (favourable-risk only). These 
trends were similar among levels of recreational PA and participation in vigorous PA as well. 
Higher levels of total PA and participation in vigorous PA seemed to be associated with shorter 
time on active surveillance; however, when restricted to men who reclassified, time to 
reclassification was not associated with PA (15). Men who completed greater amounts of PA 
also had, on average, lower body mass indices. 
Results from the binary logistic regression analysis are shown in Table II. Increasing 
levels of total PA were significantly associated with a reduction in odds of reclassification when 
data were pooled (p-trend = 0.027, respectively), but not when limited to either cohort (p-trend 
= 0.092 and 0.11). Increased MET-hrs/week of recreational PA were associated with a reduction 
in odds of reclassification (Tertile 2 vs. 1: 0.78 [0.38-1.58] and 3 vs. 1: 0.70 [0.34-1.44]), though 
this trend did not reach statistical significant in neither cohort (p-trend = 0.52 and 0.44) nor 
when the data were pooled (p-trend = 0.33). Participation in weekly vigorous PA was associated 
with a reduction in odds of reclassification in the SHSC and RMH cohorts (0.45 [0.16 – 1.27] and 
0.27 [0.084 – 0.88], respectively). Results were highly significant upon pooled analysis (0.42 
[0.20-0.85]). 
Tests for interactions between categories of PA and participant characteristics were 
performed (Table 3). A borderline significant interaction was found between vigorous PA and 
diet score (p = 0.061) where a stronger inverse association was found at lower levels of diet 
score (first tertile 0.17 [0.052 – 0.53]; second tertile 0.38 [0.12 – 1.16]; third tertile 0.99 [0.36 – 
2.76]). Similar findings were observed between total and recreational PA with diet score; 
however, these interactions were not significant (p = 0.67 and 0.40, respectively). A borderline 
significant interaction was also found between vigorous PA and WHR where stronger inverse 
associations were found among greater ratios (first tertile 0.67 [0.22 – 2.05]; second tertile 0.46 
[0.16 – 1.36]; third tertile 0.13 [0.038 – 0.42]; p=0.079). This finding was similar for recreational 
PA but not total PA (p=0.50 and 0.93, respectively). Notable interactions between total, 
recreational or vigorous PA and age at diagnosis, time on surveillance, BMI, or tobacco or 
alcohol use were not observed. 
Discussion 
The current study examined data collected from men initially diagnosed with 
favourable-risk PCa and managed by active surveillance at SHSC in Canada and RMH in the 
United Kingdom. The primary objective was to investigate the association between PA and PCa 
progression while on active surveillance. We found that increasing levels of total PA as 
expressed by MET-hrs/wk were inversely associated with odds of reclassification. Though this 
finding was not significant in either cohort alone, pooled results indicated a significant inverse 
linear trend. Lack of significance in single cohorts is probably due to the relatively small sample 
size, which increases the estimate of the standard error, thus reducing power to detect a 
significant reduction in odds of reclassification. The differences between odds of reclassification 
for the second vs. first tertile in the RMH and SHSC cohorts could be due to variation in the 
method of reclassification between cohorts among other healthcare and population variables. 
The inverse association between PA and PCa reclassification is consistent with previous 
literature indicating a protective effect of PA on PCa risk and progression (i.e. biochemical 
recurrence, bone metastasis, secondary treatment, and PCa death) (6-11). 
Increasing levels of recreational PA appeared to be inversely associated with odds of 
reclassification in both cohorts, though this finding was not significant even when data were 
pooled. Lack of significance might be attributed to the small sample size given the weak nature 
of the association. However, a highly powered meta-analysis found that increased participation 
in recreational PA to be only borderline significantly associated with a reduced risk of PCa (6). 
Vigorous PA was significantly associated with a reduction in odds of reclassification in both 
cohorts. Findings did not significantly or notably change when including total PA as a covariate, 
indicating that the association was due to intensity rather than duration of PA. These results are 
consistent with previous studies indicating an inverse association between vigorous PA and risk 
of PCa progression even with modest amounts of vigorous PA (i.e. biochemical recurrence, 
secondary treatment, bone metastasis, PCa death) (9,10).  
 The protective association between PA and PCa reclassification can be explained by a 
number of biological mechanisms  (22). Of particular interest is the favorable modification of 
the hormonal milieu. Increased levels of PA have been found to reduce the bioavailability of 
androgens and insulin like growths factors  (22-24). These hormones stimulate the androgen 
receptor in cancerous prostatic epithelial tissue, increasing proliferation and progression  (25). 
Studies also suggest a possible association between increased PA and reduced androgen 
receptor content in prostatic epithelial tissue  (26,27). The combined effect of reduced 
hormonal bioavailability and androgen receptor content would reduce androgen receptor 
stimulation, which is crucial in PCa proliferation  (25). Other pathways such as reduced 
oxidative stress and inflammation, and increased immune surveillance have also been 
implicated in the protective association between increased PA and PCa  (22).  
Strengths and Limitations 
 This study is the first to examine the association between multiple categories of PA and 
PCa progression in the context of active surveillance. Strengths of our study design include 
classification of the outcome variable using a comprehensive set of clinical and pathological 
parameters including Gleason score, measures of prostate-specific antigen and clinical staging. 
The PA section has been previously validated in nine countries and demonstrates weak to 
moderate reliability with objective measures (i.e. pedometer and accelerometer)  (18). In 
addition, statistical control for a range of potential confounders was considered.  
There are certain limitations of this study that should be considered. The retrospective 
nature of the study leaves data prone to recall bias. Since a number of factors may influence 
memory of participation in PA such as cognitive function, regularity of PA (e.g. scheduled fitness 
classes versus house maintenance) and memory assistance (e.g. presence of companion or 
family member), it is likely that recall bias would increase variation and bias findings toward the 
null. Though it has been found that cases (i.e. reclassified group) tend to remember exposures 
better than non-cases (i.e. favorable-risk) (28), it is unlikely that recall accuracy was enhanced 
among the reclassified compared to favorable-risk group, as variation in self-report PA was 
similar (15).  
Differential questionnaire administration raises two major concerns. In-person 
compared to participant administration has been shown to elevate social desirability bias (21), 
which might explain increased PA participation among SHSC compared to RMH participants. 
Other variables such as geography (e.g. Canadians tend to travel greater distances between 
points of interest), and patient selection (i.e. differences in clinical guidelines might select 
different populations between cohorts that perform different amounts of PA) may also explain 
these discrepancies. The GPAQ was designed to be administered in-person, which might reduce 
variability due to individual interpretation. This might explain the narrower confidence intervals 
observed among the SHSC compared to the RMH cohort.  
Another concern is that the reclassified group from the SHSC cohort included men who 
sought radical treatment regardless of disease status. Cancer-related anxiety has been found to 
independently predict receipt of radical treatment among men on active surveillance (29). Since 
PA might reduce such anxieties (30), the psychological effects might have contributed to our 
findings rather than just the biological effects of PA. However, only 3 men opted for treatment 
without clinical recommendation, and men who forewent treatment despite recommendation 
were excluded, making psychological influence a trivial concern. Finally, prostate-specific 
antigen screening was not examined as a covariate. Since it increases the likelihood of 
favourable-risk diagnosis and is associated with health-conscious behaviours (31), it has 
potential to confound the inverse association between PA and PCa progression noted here. 
However, lack of association and confounding among other health-conscious behaviors (e.g. 
diet, BMI, WHR and tobacco and alcohol use) suggests that inclusion of screening as a covariate 
would not significantly change study results. 
Summary 
 The study finds increased levels of total and participation in vigorous PA to be 
associated with a reduction in odds of reclassification among men diagnosed with favourable-
risk PCa and managed by active surveillance. Results for increased recreational PA were less 
convincing, though still favourable. These findings did not notably change at different age 
groups, or between cohorts lending further strength to our findings. In light of these results and 
considering that PA has been found safe and effective in improving overall health among PCa 
patients (13), oncologists should encourage men on active surveillance to increase levels of PA. 
Given the limitations of this study, suggesting specific PA levels sufficient in reducing PCa 
progression would be inappropriate. Instead, oncologists should make a referral to 
professionals with experience in exercise programming for cancer patients (e.g. certified 
exercise physiologist) who can assess patients and provide tailored exercise programs that 
maximize health benefit and safety. 
To overcome limitations within our study, future prospective observational studies with 
larger sample sizes of men undergoing active surveillance and objective measures of PA are 
warranted. Clinical trials are also warranted to understand the feasibility of exercise 
interventions among active surveillance patients and to accurately establish exercise 
prescriptions effective in tertiary prevention. A clinical trial involving lifestyle intervention in an 
active surveillance population is already underway, involving increased vegetable intake (32).  
Results suggest that clinical trials involving lifestyle intervention among active surveillance 
patients are feasible. 
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